Sievers B, Gelbart T, Tan G
STAR Protoc. 2023; 3(4):101835.
PMID: 36595901
PMC: 9579189.
DOI: 10.1016/j.xpro.2022.101835.
Salazar-Garcia M, Acosta-Contreras S, Rodriguez-Martinez G, Cruz-Rangel A, Flores-Alanis A, Patino-Lopez G
Front Microbiol. 2022; 12:817200.
PMID: 35095820
PMC: 8795712.
DOI: 10.3389/fmicb.2021.817200.
Belian E, Noseda M, Abreu Paiva M, Leja T, Sampson R, Schneider M
PLoS One. 2015; 10(6):e0125384.
PMID: 26047103
PMC: 4457652.
DOI: 10.1371/journal.pone.0125384.
Okada M, Matsuda H, Okimura Y
PLoS One. 2013; 8(1):e54437.
PMID: 23342159
PMC: 3546981.
DOI: 10.1371/journal.pone.0054437.
Whitt M
J Virol Methods. 2010; 169(2):365-74.
PMID: 20709108
PMC: 2956192.
DOI: 10.1016/j.jviromet.2010.08.006.
Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.
Barsov E, Payne W, Hughes S
J Virol. 2001; 75(11):4973-83.
PMID: 11333876
PMC: 114900.
DOI: 10.1128/JVI.75.11.4973-4983.2001.
No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures.
Shahabuddin M, Sears J, Khan A
J Clin Microbiol. 2001; 39(2):675-84.
PMID: 11158127
PMC: 87796.
DOI: 10.1128/JCM.39.2.675-684.2001.
Virus maturation by budding.
Garoff H, Hewson R, Opstelten D
Microbiol Mol Biol Rev. 1998; 62(4):1171-90.
PMID: 9841669
PMC: 98943.
DOI: 10.1128/MMBR.62.4.1171-1190.1998.
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
Abe A, Chen S, Miyanohara A, Friedmann T
J Virol. 1998; 72(8):6356-61.
PMID: 9658075
PMC: 109781.
DOI: 10.1128/JVI.72.8.6356-6361.1998.
A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
Arai T, Matsumoto K, Saitoh K, Ui M, Ito T, Murakami M
J Virol. 1998; 72(2):1115-21.
PMID: 9445007
PMC: 124585.
DOI: 10.1128/JVI.72.2.1115-1121.1998.
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
Krasnykh V, Mikheeva G, Douglas J, Curiel D
J Virol. 1996; 70(10):6839-46.
PMID: 8794325
PMC: 190731.
DOI: 10.1128/JVI.70.10.6839-6846.1996.
Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae.
Matsubara T, Beeman R, Shike H, Besansky N, Mukabayire O, Higgs S
Proc Natl Acad Sci U S A. 1996; 93(12):6181-5.
PMID: 8650240
PMC: 39210.
DOI: 10.1073/pnas.93.12.6181.
Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.
Barsov E, Hughes S
J Virol. 1996; 70(6):3922-9.
PMID: 8648729
PMC: 190270.
DOI: 10.1128/JVI.70.6.3922-3929.1996.
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
Burns J, Friedmann T, Driever W, Burrascano M, Yee J
Proc Natl Acad Sci U S A. 1993; 90(17):8033-7.
PMID: 8396259
PMC: 47282.
DOI: 10.1073/pnas.90.17.8033.
Basis for selective incorporation of glycoproteins into the influenza virus envelope.
Naim H, Roth M
J Virol. 1993; 67(8):4831-41.
PMID: 8392617
PMC: 237870.
DOI: 10.1128/JVI.67.8.4831-4841.1993.
Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.
Clapham P, Nagy K, Weiss R
Proc Natl Acad Sci U S A. 1984; 81(9):2886-9.
PMID: 6326149
PMC: 345177.
DOI: 10.1073/pnas.81.9.2886.
Antibody-mediated neutralization of virus is abrogated by mycoplasma.
Dickson C, Elkington J, Hales A, Weiss R
Infect Immun. 1980; 28(3):649-53.
PMID: 6249748
PMC: 550999.
DOI: 10.1128/iai.28.3.649-653.1980.
Heterogeneity of vesicular stomatitis virus particles: implications for virion assembly.
Lodish H, Porter M
J Virol. 1980; 33(1):52-8.
PMID: 6245248
PMC: 288522.
DOI: 10.1128/JVI.33.1.52-58.1980.
Interaction of mRNA with proteins in vesicular stomatitis virus-infected cells.
Adam S, Choi Y, Dreyfuss G
J Virol. 1986; 57(2):614-22.
PMID: 3003393
PMC: 252776.
DOI: 10.1128/JVI.57.2.614-622.1986.
Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.
Clapham P, Blanc D, Weiss R
Virology. 1991; 181(2):703-15.
PMID: 1673040
PMC: 7131431.
DOI: 10.1016/0042-6822(91)90904-p.
